Finance

Lists
Why is 4572 down 11.98%?
Dive Deeper
4572:TYO
Carna Biosciences, Inc.
¥360.00
-11.98%
(-49.00) 1D
Oct 7, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4572...
Open
¥377
High
¥379
Low
¥360
Mkt. cap
7.68B
Avg. vol.
126.65K
Volume
709.30K
52-wk high
¥512
52-wk low
¥200
EPS
-¥111
Shares outstanding
10.14M
No. of employees
61
Open
¥377
High
¥379
Low
¥360
Mkt. cap
7.68B
Avg. vol.
126.65K
Volume
709.30K
52-wk high
¥512
52-wk low
¥200
EPS
-¥111
Shares outstanding
10.14M
No. of employees
61
News stories
From web sources and news partners
About Carna Biosciences, Inc.
CEO-
Employees61
FoundedApr 10, 2003
Headquarters-
SectorHealth care
Websitecarnabio.com
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
144.33M
183.57M
183.64M
217.36M
Cost of goods sold
47.38M
66.26M
52.35M
56.65M
Cost of revenue
47.38M
66.26M
52.35M
56.65M
Research and development expenses
-
1.85B
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
595.96M
-1.21B
589.72M
656.28M
Operating expense
595.96M
640.46M
589.72M
656.28M
Total operating expenses
643.35M
706.72M
642.07M
712.93M
Operating income
-499.01M
-523.14M
-458.44M
-495.56M
Other non operating income
-39.00K
-770.00K
369.00K
-11.37M
EBT including unusual items
-543.38M
-571.28M
-512.11M
-525.89M
EBT excluding unusual items
-535.04M
-555.94M
-488.97M
-517.03M
Income tax expense
572.00K
-287.00K
1.12M
-122.00K
Effective tax rate
-0.11%
0.05%
-0.22%
0.02%
Other operating expenses
-
-
-
-
Net income
-543.95M
-570.99M
-513.24M
-525.76M
Net profit margin
-376.88%
-311.05%
-279.49%
-241.88%
Earnings per share
-
-
-
-
Interest and investment income
993.00K
-
932.00K
1.07M
Interest expense
-33.90M
-17.72M
-13.19M
-20.81M
Net interest expenses
-32.91M
-17.72M
-12.25M
-19.75M
Depreciation and amortization charges
-
-
-
-
EBITDA
-491.20M
-515.40M
-
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps